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Neurocognitive deficits are common sequelae of cardiacoperations, affecting both long-term functional out-come and quality of life. The cause of perioperativecerebral injury remains incompletely understood, but it
is multifactorial and likely represents a complex interaction among
cerebral microembolization, global hypoperfusion, temperature
modulation, and inflammatory processes. In addition, genetic fac-
tors have been shown to influence neurocognitive outcome after
cardiac operations. Specifically, the presence of the APOE4 allele,
one of the common human polymorphisms of the gene encoding
apolipoprotein E (apoE), has been associated with a worsened cog-
nitive outcome after coronary artery bypass grafting.1 This is con-
sistent with prior clinical and experimental observations implicat-
ing the APOE4 allele in poor outcome after a variety of acute brain
insults, including stroke, intracranial hemorrhage, and traumatic
brain injury.2
In addition to its role in cholesterol transport, recent reports
have suggested that apoE plays a biologically relevant role in
downregulating the systemic and central nervous system immune
responses.3,4 Thus, one potential mechanism by which apoE influ-
ences outcome after acute brain injury is by modulating the inflam-
matory response. In this study we sought to determine whether
APOE genotype influences the systemic inflammatory response to
cardiopulmonary bypass (CPB).
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Methods
After obtaining institutional review board approval, 338 consenting
patients undergoing elective coronary artery bypass grafting with
hypothermic CPB (30°C-32°C) were studied. After placement of inva-
sive monitors, anesthesia was induced and maintained with midazo-
lam, fentanyl, and pancuronium. The perfusion apparatus consisted of
a membrane oxygenator, a roller pump, and a 40-µm arterial line fil-
ter maintaining nonpulsatile CPB flows of 2 to 2.4 L · min–1 · m–2.
Arterial PCO2 and PO2 values were maintained at 35 to 40 mm Hg
(uncorrected for body temperature) and 150 to 250 mm Hg, respec-
tively. The hematocrit level during CPB was greater than 0.18, and the
mean arterial pressure was maintained between 50 and 90 mm Hg.
Blood samples were taken at baseline (before induction of anes-
thesia), at the end of CPB, and at 4.5, 24, and 48 hours postopera-
tively. Collected blood was centrifuged (10,000g), and the resulting
supernatant was immediately frozen at –70°C until analysis was com-
pleted. Measurements of the representative proinflammatory
cytokine interleukin 1β (IL-1β) and the anti-inflammatory IL-1β
receptor antagonist (IL-1ra) were performed by Biosite Diagnostics
(San Diego, Calif) using a Genesis Robotic Sample Processor 200/8
(Tecan; Research Triangle Park, NC). All assays were performed in a
10-µL reaction volume in 384-well microplates, with the amount of
bound antigen detected by means of alkaline phosphatase–conjugat-
ed secondary antibodies and AttoPhos substrate (JBL Scientific, San
Luis Obispo, Calif). APOE genotype was determined from each
patient by a polymerized chain reaction from preoperative whole-
blood samples.1
Demographic data were compared with either the Fisher exact test
for binary variables or the Wilcoxon 2-sample rank sum test for con-
tinuous data. A nonparametric generalized estimating equations5
approach, which accounts for the within-subject cytokine correlation,
was adopted to compare, after controlling for age and CPB time, the
overall temporal pattern of cytokine response between those patients
with at least one copy of the APOE4 allele and those without.
Results
Patient demographics are presented in Table 1. Ninety-four (28%)
patients had at least one copy of the APOE4 allele. With the excep-
tion of age (APOE4 allele, 61 ± 10 years vs no APOE4 allele, 64
± 11 years; P = .03), there were no significant demographic differ-
ences between groups. The overall temporal pattern of IL-1β and
IL-1ra levels were analyzed and modeled, while controlling for
both age and CPB time, to examine for an APOE4 effect. There
were no significant overall differences between groups with and
without the APOE4 allele with respect to the IL-1β levels over
time (P = .8). However, compared with the group without the
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APOE4 allele, the group with the allele had a lower IL-1ra
response overall (P = .04, Figure 1).
Discussion
Our results suggest that after the initiation of CPB, the presence
of the APOE4 allele is associated with decreased levels of IL-
1ra, although IL-1β levels rise in a similar fashion, regardless of
APOE genotype. This may lead to a relatively unopposed proin-
flammatory response to CPB in these patients and is consistent
with prior reports suggesting that apoE plays a biologically rel-
evant role in modulating the systemic and central nervous sys-
tem inflammatory responses.3,4 Glial activation is associated
with the endogenous cerebral inflammatory response and leads
to the production of reactive oxygen species, glutamate, and
other neurotoxic mediators that may contribute to neuronal
injury. Thus, an enhanced inflammatory reaction associated with
the APOE4 allele may be one mechanism to explain the obser-
vations that patients with the APOE4 allele have worse neu-
rocognitive outcomes after CPB.
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TABLE 1. Demographics
Patients with Patients without
APOE4 (n = 94) APOE4 (n = 244) P value
Age (y) 61 ± 10 64 ± 11 .03
Male sex (%) 64 70 .24
DM (%) 26 36 .09
HTN (%) 63 58 .24
Total cholesterol (mg/dL) 195 ± 40 189 ± 41 .45
CPB time (min) 107 ± 34 108 ± 35 .99
Crossclamp time (min) 57 ± 22 57 ± 23 .86
Grafts 3.3 ± 0.8 3.2 ± 0.9 .19
Inotropic support* (%) 36 33 .45
Values are given as means ± SD where indicated.
DM, Diabetes mellitus; HTN, hypertension.
*Post-CPB requirement for inotropic support (dopamine or epinephrine).
Figure 1. The overall temporal pattern of IL-1ra release (mean ±
standard error of the mean) in 338 patients undergoing CPB for
coronary artery bypass grafting was  lower (P = .04)  in those hav-
ing the APOE4 allele (E4), thus representing a decreased anti-
inflammatory response to CPB in these patients.
